| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.25 | 4e-05 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0006 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |